MedTrace Logo

French HIV-HBV Cohort

NCT02889094 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 152

Last updated 2018-04-26

No results posted yet for this study

Summary

The overarching purpose of this study is to further understand the reasons for and clinical implications of persistent HBV infection in patients co-infected with HIV and HBV in the era of highly effective antiviral treatment against both viruses.

Conditions

Interventions

OTHER

Routine care

Routine care recommended for patients co-infected with HIV and hepatitis B virus (per European Association for the Study of the Liver and European AIDS Clinical Society guidelines).

Sponsors & Collaborators

  • ANRS, Emerging Infectious Diseases

    collaborator OTHER_GOV

  • Sidaction

    collaborator OTHER

  • Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba

    lead OTHER

Principal Investigators

  • Anders Boyd, MPH, PhD · INSERM UMR S 1136

  • Karine Lacombe, MD, PhD · INSERM UMR S 1136

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2018-03-31
Completion
2018-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02889094 on ClinicalTrials.gov